These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30855377)

  • 21. Gender differences in incidence and outcomes of urothelial and kidney cancer.
    Lucca I; Klatte T; Fajkovic H; de Martino M; Shariat SF
    Nat Rev Urol; 2015 Oct; 12(10):585-92. PubMed ID: 26436686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Murai M
    Eur Urol; 2008 Jul; 54(1):140-1. PubMed ID: 18160208
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database.
    Patard JJ
    Eur Urol; 2008 Jul; 54(1):141-2. PubMed ID: 18160206
    [No Abstract]   [Full Text] [Related]  

  • 24. Kidney cancer: from genes to therapy.
    Webster BR; Rompre-Brodeur A; Daneshvar M; Pahwa R; Srinivasan R
    Curr Probl Cancer; 2021 Aug; 45(4):100773. PubMed ID: 34261604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic basis of bilateral renal cancer: implications for evaluation and management.
    Linehan WM
    J Clin Oncol; 2009 Aug; 27(23):3731-3. PubMed ID: 19597019
    [No Abstract]   [Full Text] [Related]  

  • 27. Obesity: The fat advantage.
    Gupta S
    Nature; 2016 Sep; 537(7620):S100-2. PubMed ID: 27626776
    [No Abstract]   [Full Text] [Related]  

  • 28. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004.
    Woldrich JM; Mallin K; Ritchey J; Carroll PR; Kane CJ
    J Urol; 2008 May; 179(5):1709-13; discussion 1713. PubMed ID: 18343430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma.
    Long GD
    Curr Opin Oncol; 1997 May; 9(3):301-6. PubMed ID: 9229154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of molecular markers in the staging of renal cell carcinoma.
    Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renal cell carcinoma molecular biology. Prognostic and therapeutic usefulness].
    Zudaire Bergera JJ; Rincón Mayans A; Rioja Zuazu J; Barba Abad J; Romero Vargas L; Algarra Navarro R; Tienza Fernández A; Robles García JE; Rosell Costa D; Berián Polo JM; Pascual Piédrola JI
    Arch Esp Urol; 2013; 66(1):23-32. PubMed ID: 23406797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hot topics in kidney cancer 2010.
    Merseburger AS; Ljungberg B; Doehn C
    World J Urol; 2010 Jun; 28(3):245-6. PubMed ID: 20443008
    [No Abstract]   [Full Text] [Related]  

  • 33. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
    Shuch B; Vourganti S; Ricketts CJ; Middleton L; Peterson J; Merino MJ; Metwalli AR; Srinivasan R; Linehan WM
    J Clin Oncol; 2014 Feb; 32(5):431-7. PubMed ID: 24378414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAMA patient page. Kidney cancer.
    Torpy JM; Lynm C; Golub RM
    JAMA; 2011 Jul; 306(2):226. PubMed ID: 21750304
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients.
    Hurst FP; Jindal RM; Fletcher JJ; Dharnidharka V; Gorman G; Lechner B; Nee R; Agodoa LY; Abbott KC
    Urology; 2011 Jun; 77(6):1271-6. PubMed ID: 21459420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study.
    Woldu SL; Matulay JT; Clinton TN; Singla N; Freifeld Y; Sanli O; Krabbe LM; Hutchinson RC; Lotan Y; Hammers H; Hannan R; Brugarolas J; Bagrodia A; Margulis V
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1221-e1235. PubMed ID: 30217763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.
    Sun M; Thuret R; Abdollah F; Lughezzani G; Schmitges J; Tian Z; Shariat SF; Montorsi F; Patard JJ; Perrotte P; Karakiewicz PI
    Eur Urol; 2011 Jan; 59(1):135-41. PubMed ID: 21035250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years.
    DI Trapani E; Dell'oglio P; Larcher A; Nini A; Muttin F; Cianflone F; Dehò F; Matloob R; DI Trapani D; Freschi M; Salonia A; Briganti A; Montorsi F; Bertini R; Capitanio U
    Anticancer Res; 2018 Jul; 38(7):4123-4130. PubMed ID: 29970539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal-cell carcinoma.
    Motzer RJ; Bander NH; Nanus DM
    N Engl J Med; 1996 Sep; 335(12):865-75. PubMed ID: 8778606
    [No Abstract]   [Full Text] [Related]  

  • 40. Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T
    Marchioni M; Martel T; Bandini M; Pompe RS; Tian Z; Kapoor A; Cindolo L; Autorino R; Briganti A; Shariat SF; Schips L; Karakiewicz PI
    World J Urol; 2017 Dec; 35(12):1899-1905. PubMed ID: 28849260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.